pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-561 |
Genomic Coordinates | chr2: 188297492 - 188297588 |
Synonyms | MIRN561, hsa-mir-561, MIR561 |
Description | Homo sapiens miR-561 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-561-3p | |||||||||||||||||||||||||||||||||||||||||||||||||
Sequence | 61| CAAAGUUUAAGAUCCUUGAAGU |82 | |||||||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||||||
Experiments | SAGE | |||||||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FRS2 | ||||||||||||||||||||
Synonyms | FRS1A, FRS2A, FRS2alpha, SNT, SNT-1, SNT1 | ||||||||||||||||||||
Description | fibroblast growth factor receptor substrate 2 | ||||||||||||||||||||
Transcript | NM_001042555 | ||||||||||||||||||||
Other Transcripts | NM_006654 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FRS2 | |||||||||||||||||||||
3'UTR of FRS2 (miRNA target sites are highlighted) |
>FRS2|NM_001042555|3'UTR 1 GCCTGGAAAGCATTGTGTTGTTTGCACCTTTGTGAAGTTTTTAAAAATGAAGATGCAAGTGCTTCATTTTCATTTCTAAA 81 CACTAACTCCTTTTATAGACTGATAAAATTTTTTTCTGAATATTTCATGTGCATCTTTAACTAAAGGGAATTAATGTAGA 161 GCAGGTACTCCTTAAAGAACACTAATTTCATTATATACTACTCGTTGTACAGCAGCATTCCCGTTTTCACAGTGCCTATT 241 TAAAATGAGAGTTGAAGTAAATGACATGCTGGTTGATTTTTATCAATATTCTGGACTTAACGCATACCTTTCATGTCTAA 321 GTCATGGTTGGCTTTTAAAACTTTTTATAAAGCCTCTTGACAATGTACATTGCTAACAGGTAACTATAGGCTTTGAAAGT 401 AATGCTCGTAGATTCAGTGTTCACAGTATGTGGCCTCCAGCATGTAACATGAGGAATCCTTTATTTCATTAATTAATGGC 481 TTTTTGACTTGAGCCAAAACATATGTAAAGGAAACAGAAGTACCGCACCTCCTCTTACACCAGTCAGCTCCTTTGCCTTC 561 AGTGTTACTAGAAAGCGGCCTGTGTCCATGAGTGTGCTTTGCTGTTGGTGCACTGAAAGGCAGGAAGGAGACAAGATTTT 641 CTATTTACTCATCTCATGATGTCATTTGAAGGGCATGTCCAGATATCTTAAAATTATAATAGGCTCAAGAATCAGTCTCA 721 GGTCACTTTACCCAAAAACATTTGAAAATCTGAACCACAATCTCCTGAAAGTTTTTCTCCTATAGATTGTTGACAACACA 801 TTGTTTTCTGGAGGCATTTGTGCCATTAGGTTTCCATTTATCTTCAGTTTTTTTCTTTGGTGTTTGGGATGTCTTATTTT 881 GTTGCCTTATGTCCTTTTCAATTTAAAATGTTTGAGTTTGTATATAGTTTTGAAATTGGATTATGTGTTCATTGTTGTTT 961 AGTTTGCATTTTTGTCAAATTATGGTTTTGAAGGTTCATTTGGAACTTACTGTTAGTCTGTAACAGGGTTGCCCTTGTCC 1041 AGTATTTATTTATAAGCTGTTTACTTTTCAAGTTGATAAAAACATTCTCCAATTCTAAATTTGCTTGTGTCCATAGGTGA 1121 TCTCTTTAGCAAACTGAGAAAAAAAGGAAGCTACTTTTAACATGCAAAGTTCCCTCAAGGTGTACCGTGTTGTCTCTGTG 1201 GGCACTCTTCCCCAGCACTTTAGCAGTAATTCCCCCAGCTACACGCTGCAGTTGTACTCTGCCCACTCTAGTGTTCCTCA 1281 GCTCTGCTGTCCTTTTACTTGTAGCTGGATCTTTGATTATCCTTCGATTTCCATGAAATATTAATATTGTTGCCAGCATA 1361 GCAGGTACAGTGGAAGTCTTGTAGCAGTGAGATTGTATCATAATTTAGGATTTAAAATGAATTAAAGTTTATATAAACTG 1441 AAGAGTCTCCATATGTCAAACTCTTGGAAAATCAAAGATGTTCCAATTTCCTAAACACTAGAGAATACGAGAGAAGGTAG 1521 AGTGGAAAAGGTTAGGTAACCTTGCAAAATATTTTACTATTTTCTCTAAATATGAGGAAGTTTGAGATTATGATCTGGAT 1601 CTACCAGATATAACTAAGGTTAATTTAGCATGAAAAAGTTTTAGTCATATTGGCATCCAACCTATTCAGTAACCGAATCA 1681 TAGGACAATGATGGATTAGGAGAACAATAGAGTGGGATCATTATAAAGAAAATAAATTATTAAAGGTGTCTTTATCGTTT 1761 TAGTGCCATTTTTAGTGTCTTTACTATAAATCAATATCAGTGTATTTTATCATTCTATGTGCATAGCAGAATTTTCTTTT 1841 CTCCCTTTTGTTCCCCTGTGAACTTGGTGCTTATTAAAGTGCTCACTGTTCTCTTAAAAGAGAGCAGTGGTATAGGTGTG 1921 CAGTTTCCATGATGCAGGTTCCATTTTTAATATATTGTTCCACTTATCCTTTCTTCTGAGTAAATTGCTAATTGTGCCAA 2001 ATTTATGTAATAGTTTTTGTAATGTGGAATAAGAATTATGATGGAACCATTGCACATTTTTTTCTGAAACAGCCAGTCAA 2081 GGCAGAACATTAATCTCCAAATGCAAGGGCTGATCTATTTATTCATTTTGGAGGTTGGGTACTTTATTCTTTCTTTCCGT 2161 CATCCTTTTCATTGTTTCCCCCGGATTCTAATTAGTTTTTATTTTTTTTAGATAACTCCAATATAATCATTACAGTTTAT 2241 GCTTTAAATACTATGTGCTTTAAAAAGGAAAATGGGACCAATTTGTCTGCTAAGAATTTGATTTTAGGTACTATAAGAGT 2321 ATTAGGAAAATATATACAACTGGTGTTAATTTCTAGATATTTTCTAGAAATCACTTGTGTTCCTATTTAATAAAAGGTAA 2401 TTTAGAATACTACTTGTCCTTTGCAGTAGTTTAGTAATGGGCATTAAGCTGTGTCCTCGAAGGATGTACCTATTACTAGG 2481 TGCATTTTAGAATGAAATATTGATATTTTATTAGCATATAATTGTGGCCATATATCTCAGATTTTCTGAGGCAGATCTAA 2561 TTTTAGATAATTCTGTTGGTAGACCATGTGATCCTTCTTTTTGGTTTTGGAAATATAATCATTGTTAATGTTTTCCCTCC 2641 AAATAGAATACTGTTTTATCCATACAAATCATAACAGCATCTATCCCATGCTAGGGTTGGAAACTGATATTGGTATTACT 2721 TGTGTTTTTTCTTAGTGTGTTTTATTTCCCAGTTTCATCTTCTTCTAAAAATGAAAATATGGTGCCTTCCCTCCCTCCAG 2801 GAAGACTGGCAAATATTTCCTTTTATTTACTGCTGCTGTGGAGTGATGAGATATGCACTTTACTCTTTAAGATTCAGCAA 2881 AAAGCTTTTCACTTCTCAGTATATCCAGAATACATCATATCTGGGACTTAGGAAAATTTGCCAAGCAATCTTTGTTTTTA 2961 TAGATACTAATGTTGACCCTCTCCAGCGTTCAATGTTATAAATAGAACAAGTCAAGCTAGTGTTTATCTCCTCCCCCTCC 3041 CCAAAACTGTGGCACAGCATATAAAAATGTACCTCAATAATGTTCTATTAAAAATGGGACAGGGGCCTTATGTTTTCATA 3121 ATTTCCCAACAATGTGCCGCCATATTTTTGCCTCAAGGTAAAGGTTTTAACAGATGAAAAAGTACTTCCCAATTCCCCCG 3201 TGCTATTCCTAACCTATAATGCCCAAATGTTTTGTGCAATGTGTAGTGTGTGTGTATAAATACATATATTCTTGAAATAG 3281 ACATACCATCAGAGACATCATTCACAAGTAACTGATGTATTGGCATCTCATTCATATTTCTGATGTGTGAGGTATATGGT 3361 ACTAATTACCTTTTCCTTGATGTTTGCCAAATTTGAATAAAGGCATTGGTACGAAATTACAGAATGTAAAGAAAATGTTT 3441 TTGGCTTGAAAAATTAACATATTTTATGACGTACCACAGTATACTCTGCCCAAACCAGCACCCTATCTATCTTTCCTGTT 3521 CTTTACATCCCTGTTCCCCATCCCTACTTCCTCATTTTTGGTATAACACAGTTCTTTTGTAGCATCATTATAATTGCAGT 3601 TCTATGGCAATTGGACAGTTATAGCATGGAAACAGACTGGTATAAGTAGTACAGTAGTCACCAGTGTGCCACATTTGCAT 3681 TAGTAATGCAAAATATACATTTTATAAAGGACAAACTTTGTGTTATGTTTTATTTTCATTACATTGTATAATATTGTAAG 3761 ACTATTGTATGTCCTAATTTGCATTATAAATGTTTTTTTCCTACGTAAAGGCATAAATATAGCAACTTTGTATAAAGGTA 3841 GCTTATTAGATTTTTAATTTTTTCTTTTATAAAAAATTGTCCAACAGTGGGACTACCATTGCCAAATTGTATATGAAATA 3921 TGAATTTTACCCCCATGGTTAATTTCTTTTATAAACATTCCATATTTCTCTAATAAAAAGACATAAGTGATACTGTACTA 4001 TGCATACATTGTATCTTAATGCTGTTTCAGATCAGCATTTTAAATTTTGGTTTGCATTTTTAATATTGGCAAAACGTAAC 4081 CACTGTTAATTAAAATAAAACCTTGTTGTATATGTAACAACATAATTTTCCCTCTATCCCTTCCCACCCTTTGTTCTCTA 4161 TTTCTCCCTATCAGTGCCAACTTCATACATTTTGTAGCATGGCAATAAAATATAACTTTTACACTGAGGCCGAGTGTGGC 4241 TTTTTGGAGGAAGTGGGGATGGGACGATTGCCCTCTAGTTGTCCTTTGCATATGACTGTTTTTTGCCATATAAGCCATGT 4321 CATCAGGCATGAAAAGTTTTCTCATATATGATGTAAACTTGCTTTTAAGGACAAGTGTGAATGTGCTTTTTAAGCTTAAT 4401 TTTTGTCATGACAACTAATTTTTTTTATCTTTGGAGAAGTCAGAGTTCTTTACAATCAAACGTTTATTAACTGGAGTACT 4481 TAGAATAAGCTAGTAATTGAATTTAGTTCAAGGGCTAAGCAACACATTTTTAAATCCTTATTTATTGTAGAGTATTAGTA 4561 TACTGTCCTACAAATTATGTAAAATATGGTTTAATATTAGATGACTTTGGATTTTGCAATGCCTTACTGTTGTCATTCTA 4641 GCATAAATATCCATAATGAGGTACTCAAGTTGATACTGGAAGCTGAGCTGATCATACACTGACCTGAAGCATTCATGAAA 4721 AGCTGCTTTATTGAATAAAGTCTGATTGGAGTTCTTTTCATGCTCACTTTCCCCTTATTGCTGAAAGTAGATTGCAATAA 4801 AACCCCAATAAAACGTTTGGTCGGATATCTACTTAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-3 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796040. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796040 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000550389.1 | 3UTR | UUGGCUUUUAAAACUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-561-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT072097 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 4 | ||||||||
MIRT080799 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 4 | ||||||||
MIRT088833 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT093446 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 | ||||||||
MIRT099908 | SOX4 | SRY-box 4 | 2 | 10 | ||||||||
MIRT107568 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT130135 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT136944 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT158447 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 | ||||||||
MIRT161901 | FXR1 | FMR1 autosomal homolog 1 | 2 | 2 | ||||||||
MIRT166271 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 4 | ||||||||
MIRT187291 | CLIC4 | chloride intracellular channel 4 | 2 | 4 | ||||||||
MIRT202308 | CEBPB | CCAAT/enhancer binding protein beta | 2 | 2 | ||||||||
MIRT210742 | PPP4R2 | protein phosphatase 4 regulatory subunit 2 | 2 | 2 | ||||||||
MIRT249020 | PABPC3 | poly(A) binding protein cytoplasmic 3 | 2 | 2 | ||||||||
MIRT268845 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 2 | ||||||||
MIRT304688 | GTF2E1 | general transcription factor IIE subunit 1 | 2 | 2 | ||||||||
MIRT316774 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT325708 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT327970 | CHIC1 | cysteine rich hydrophobic domain 1 | 2 | 6 | ||||||||
MIRT328758 | DHODH | dihydroorotate dehydrogenase (quinone) | 2 | 2 | ||||||||
MIRT356391 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 2 | 2 | ||||||||
MIRT437448 | NR0B1 | nuclear receptor subfamily 0 group B member 1 | 1 | 1 | ||||||||
MIRT441383 | FRS2 | fibroblast growth factor receptor substrate 2 | 2 | 2 | ||||||||
MIRT442496 | PCDH10 | protocadherin 10 | 2 | 4 | ||||||||
MIRT444054 | PROX2 | prospero homeobox 2 | 2 | 2 | ||||||||
MIRT446062 | RABIF | RAB interacting factor | 2 | 2 | ||||||||
MIRT446714 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT456384 | CRB1 | crumbs 1, cell polarity complex component | 2 | 2 | ||||||||
MIRT457022 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT457056 | NEGR1 | neuronal growth regulator 1 | 2 | 2 | ||||||||
MIRT457353 | RAD51AP1 | RAD51 associated protein 1 | 2 | 2 | ||||||||
MIRT466850 | STX6 | syntaxin 6 | 2 | 2 | ||||||||
MIRT471347 | PELO | pelota mRNA surveillance and ribosome rescue factor | 2 | 2 | ||||||||
MIRT474051 | LONRF1 | LON peptidase N-terminal domain and ring finger 1 | 2 | 2 | ||||||||
MIRT479058 | CNOT6L | CCR4-NOT transcription complex subunit 6 like | 2 | 8 | ||||||||
MIRT479398 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 8 | ||||||||
MIRT492072 | TMED7 | transmembrane p24 trafficking protein 7 | 2 | 2 | ||||||||
MIRT492810 | PCBP1 | poly(rC) binding protein 1 | 2 | 6 | ||||||||
MIRT494861 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT496888 | TMTC2 | transmembrane and tetratricopeptide repeat containing 2 | 2 | 2 | ||||||||
MIRT498041 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT500856 | SYPL1 | synaptophysin like 1 | 2 | 8 | ||||||||
MIRT501323 | RNFT1 | ring finger protein, transmembrane 1 | 2 | 2 | ||||||||
MIRT502795 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | 2 | 6 | ||||||||
MIRT503684 | SLC46A1 | solute carrier family 46 member 1 | 2 | 2 | ||||||||
MIRT506383 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT507320 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT507671 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 2 | 4 | ||||||||
MIRT510809 | SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | 2 | 8 | ||||||||
MIRT512260 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 6 | ||||||||
MIRT514215 | LRRC63 | leucine rich repeat containing 63 | 2 | 2 | ||||||||
MIRT517729 | NT5DC1 | 5'-nucleotidase domain containing 1 | 2 | 4 | ||||||||
MIRT520570 | TMF1 | TATA element modulatory factor 1 | 2 | 2 | ||||||||
MIRT523456 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | 2 | 6 | ||||||||
MIRT524538 | CDCA4 | cell division cycle associated 4 | 2 | 2 | ||||||||
MIRT525478 | SPIC | Spi-C transcription factor | 2 | 2 | ||||||||
MIRT532321 | GHSR | growth hormone secretagogue receptor | 2 | 2 | ||||||||
MIRT534716 | RFX7 | regulatory factor X7 | 2 | 2 | ||||||||
MIRT535042 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | 2 | 2 | ||||||||
MIRT535111 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT536665 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT537636 | ERGIC2 | ERGIC and golgi 2 | 2 | 2 | ||||||||
MIRT537701 | ELOVL6 | ELOVL fatty acid elongase 6 | 2 | 2 | ||||||||
MIRT538060 | DMD | dystrophin | 2 | 4 | ||||||||
MIRT538811 | C21orf91 | chromosome 21 open reading frame 91 | 2 | 2 | ||||||||
MIRT539270 | ANKRD28 | ankyrin repeat domain 28 | 2 | 2 | ||||||||
MIRT541158 | PABPC1 | poly(A) binding protein cytoplasmic 1 | 2 | 2 | ||||||||
MIRT543500 | MDM2 | MDM2 proto-oncogene | 2 | 4 | ||||||||
MIRT545101 | TRIM66 | tripartite motif containing 66 | 2 | 2 | ||||||||
MIRT545328 | SLC7A5P2 | solute carrier family 7 member 5 pseudogene 2 | 2 | 2 | ||||||||
MIRT545838 | ZNF275 | zinc finger protein 275 | 2 | 2 | ||||||||
MIRT546109 | USP48 | ubiquitin specific peptidase 48 | 2 | 4 | ||||||||
MIRT548100 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 4 | ||||||||
MIRT549216 | BCLAF1 | BCL2 associated transcription factor 1 | 2 | 4 | ||||||||
MIRT549705 | RBM23 | RNA binding motif protein 23 | 2 | 4 | ||||||||
MIRT550139 | ZNF138 | zinc finger protein 138 | 2 | 2 | ||||||||
MIRT551104 | TTC8 | tetratricopeptide repeat domain 8 | 2 | 2 | ||||||||
MIRT551212 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT551389 | ZNF543 | zinc finger protein 543 | 2 | 4 | ||||||||
MIRT553330 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT553885 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT554651 | ROBO1 | roundabout guidance receptor 1 | 2 | 2 | ||||||||
MIRT554879 | RCAN2 | regulator of calcineurin 2 | 2 | 2 | ||||||||
MIRT555602 | PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | 2 | 2 | ||||||||
MIRT556467 | LMNB2 | lamin B2 | 2 | 4 | ||||||||
MIRT557838 | FNBP1L | formin binding protein 1 like | 2 | 2 | ||||||||
MIRT558143 | ENC1 | ectodermal-neural cortex 1 | 2 | 2 | ||||||||
MIRT558754 | CHERP | calcium homeostasis endoplasmic reticulum protein | 2 | 2 | ||||||||
MIRT560530 | TMEM98 | transmembrane protein 98 | 2 | 2 | ||||||||
MIRT561068 | EIF4A3 | eukaryotic translation initiation factor 4A3 | 2 | 2 | ||||||||
MIRT561384 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT561460 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT561818 | NUP155 | nucleoporin 155 | 2 | 2 | ||||||||
MIRT561963 | LSM12 | LSM12 homolog | 2 | 2 | ||||||||
MIRT562183 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | 2 | 2 | ||||||||
MIRT564363 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | 2 | 2 | ||||||||
MIRT564470 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT564755 | ZNF146 | zinc finger protein 146 | 2 | 2 | ||||||||
MIRT565532 | SON | SON DNA binding protein | 2 | 2 | ||||||||
MIRT565744 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT566236 | PTCH1 | patched 1 | 2 | 2 | ||||||||
MIRT568636 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT571081 | TCHHL1 | trichohyalin like 1 | 2 | 2 | ||||||||
MIRT571559 | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta | 2 | 2 | ||||||||
MIRT572246 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 2 | ||||||||
MIRT572908 | RUNDC3B | RUN domain containing 3B | 2 | 2 | ||||||||
MIRT573201 | TTC19 | tetratricopeptide repeat domain 19 | 2 | 2 | ||||||||
MIRT573981 | DDX21 | DExD-box helicase 21 | 2 | 2 | ||||||||
MIRT614493 | LIX1 | limb and CNS expressed 1 | 2 | 2 | ||||||||
MIRT614579 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 2 | 2 | ||||||||
MIRT614898 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT615469 | BNC2 | basonuclin 2 | 2 | 2 | ||||||||
MIRT617968 | ZNF713 | zinc finger protein 713 | 2 | 2 | ||||||||
MIRT620418 | TFDP3 | transcription factor Dp family member 3 | 2 | 2 | ||||||||
MIRT623571 | ISL1 | ISL LIM homeobox 1 | 2 | 2 | ||||||||
MIRT624902 | USP6NL | USP6 N-terminal like | 2 | 2 | ||||||||
MIRT625346 | TAPBP | TAP binding protein | 2 | 2 | ||||||||
MIRT628309 | CNN3 | calponin 3 | 2 | 2 | ||||||||
MIRT630979 | ARL4C | ADP ribosylation factor like GTPase 4C | 2 | 2 | ||||||||
MIRT637274 | KLHL12 | kelch like family member 12 | 2 | 2 | ||||||||
MIRT643959 | GALNT13 | polypeptide N-acetylgalactosaminyltransferase 13 | 2 | 2 | ||||||||
MIRT649795 | LPCAT3 | lysophosphatidylcholine acyltransferase 3 | 2 | 2 | ||||||||
MIRT653573 | SLC35B3 | solute carrier family 35 member B3 | 2 | 2 | ||||||||
MIRT653997 | SCYL3 | SCY1 like pseudokinase 3 | 2 | 2 | ||||||||
MIRT654011 | SCO1 | SCO1, cytochrome c oxidase assembly protein | 2 | 2 | ||||||||
MIRT658530 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT683755 | C3orf36 | chromosome 3 open reading frame 36 | 2 | 2 | ||||||||
MIRT690907 | TOP2A | DNA topoisomerase II alpha | 2 | 2 | ||||||||
MIRT697689 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT698820 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT701625 | MYO1B | myosin IB | 2 | 2 | ||||||||
MIRT712319 | PER2 | period circadian clock 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|